The Valley Desk

ArticleJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
PubMed ID
41337691
PubMed Central ID
PMC12931865
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal